Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
E413951-10mg | 10mg | In stock | $42.90 | |
E413951-25mg | 25mg | In stock | $88.90 | |
E413951-50mg | 50mg | In stock | $147.90 | |
E413951-100mg | 100mg | In stock | $246.90 | |
E413951-200mg | 200mg | In stock | $444.90 |
EGFR Inhibitors
Synonyms | 2H-Isoindole-2-acetamide,α-(5-fluoro-2-hydroxyphenyl)-1,3-dihydro-1-oxo-N-2-thiazolyl-;(Z)-2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxoisoindolin-2-yl)-N-(thiazol-2-yl)acetimidic acid |
---|---|
Specifications & Purity | Moligand™, ≥95% |
Biochemical and Physiological Mechanisms | EAI045 is an allosteric inhibitor that targets selected drug-resistant EGFR mutants but spares the wild-type receptor. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ALLOSTERIC MODULATOR |
Mechanism of action | Allosteric modulator of epidermal growth factor receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 2-(5-fluoro-2-hydroxyphenyl)-2-(3-oxo-1H-isoindol-2-yl)-N-(1,3-thiazol-2-yl)acetamide |
---|---|
INCHI | InChI=1S/C19H14FN3O3S/c20-12-5-6-15(24)14(9-12)16(17(25)22-19-21-7-8-27-19)23-10-11-3-1-2-4-13(11)18(23)26/h1-9,16,24H,10H2,(H,21,22,25) |
InChi Key | YTUFHOKUFOQRDF-UHFFFAOYSA-N |
Canonical SMILES | C1C2=CC=CC=C2C(=O)N1C(C3=C(C=CC(=C3)F)O)C(=O)NC4=NC=CS4 |
Isomeric SMILES | C1C2=CC=CC=C2C(=O)N1C(C3=C(C=CC(=C3)F)O)C(=O)NC4=NC=CS4 |
PubChem CID | 121231412 |
MeSH Entry Terms | 2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-(1,3-thiazol-2-yl)acetamide;EAI045 |
Molecular Weight | 383.4 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2313231 | Certificate of Analysis | Oct 18, 2022 | E413951 |
B2313232 | Certificate of Analysis | Oct 18, 2022 | E413951 |
B2313233 | Certificate of Analysis | Oct 18, 2022 | E413951 |
B2313234 | Certificate of Analysis | Oct 18, 2022 | E413951 |
B2313235 | Certificate of Analysis | Oct 18, 2022 | E413951 |
Solubility | Solubility (25°C) In vitro DMSO: 76 mg/mL (198.22 mM); Water: Insoluble; Ethanol: Insoluble; |
---|
Starting at $241.90
1. Jia Y, Yun CH, Park E, Ercan D, Manuia M, Juarez J, Xu C, Rhee K, Chen T, Zhang H et al.. (2016) Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors.. Nature, 534 (7605): (129-32). [PMID:27251290] |